large – Health

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma LAUSANNE, Switzerland–(BUSINESS WIRE) APRIL 23, 2021 — ADC Therapeutics SA (NYSE: ADCT) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynlonta (loncastuximab tesirine-lpyl) for the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma after… Read More »

Sutter posts large Q3 loss due to settlement of antitrust lawsuit

Dive Brief: California hospital chain Sutter Health reported a $ 689 million loss for the third quarter ending Sept. 30. Much of that is due to a $ 575 million set-aside in anticipation of settling an antitrust lawsuit sometime next year. A state court judge will preliminarily finalize the settlement in February with a final settlement… Read More »